These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6836542)

  • 21. Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasma.
    Schoen P; Lindhout T; Hemker HC
    Br J Haematol; 1992 Jun; 81(2):255-62. PubMed ID: 1322691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1.
    Rovelli G; Stone SR; Guidolin A; Sommer J; Monard D
    Biochemistry; 1992 Apr; 31(13):3542-9. PubMed ID: 1554734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin inactivation on surfaces with covalently bonded heparin.
    Pasche B; Kodama K; Larm O; Olsson P; Swedenborg J
    Thromb Res; 1986 Dec; 44(6):739-48. PubMed ID: 3798418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of platelet factor 4 to heparin oligosaccharides.
    Denton J; Lane DA; Thunberg L; Slater AM; Lindahl U
    Biochem J; 1983 Feb; 209(2):455-60. PubMed ID: 6847629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of human alpha-thrombin with artificial surfaces and reactivity of adsorbed alpha-thrombin.
    Chuang HY; Mohammad SF; Sharma NC; Mason RG
    J Biomed Mater Res; 1980 Jul; 14(4):467-76. PubMed ID: 7400198
    [No Abstract]   [Full Text] [Related]  

  • 28. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
    Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication and characterization of heparin functionalized membrane-mimetic assemblies.
    Tseng PY; Rele SM; Sun XL; Chaikof EL
    Biomaterials; 2006 Apr; 27(12):2627-36. PubMed ID: 16368135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of fibronectin on the binding of antithrombin III to immobilized heparin.
    Byun Y; Jacobs HA; Feijen J; Kim SW
    J Biomed Mater Res; 1996 Jan; 30(1):95-100. PubMed ID: 8788110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immobilization of high-affinity heparin oligosaccharides to radiofrequency plasma-modified polyethylene.
    Yuan S; Szakalas-Gratzl G; Ziats NP; Jacobsen DW; Kottke-Marchant K; Marchant RE
    J Biomed Mater Res; 1993 Jun; 27(6):811-9. PubMed ID: 8408111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin and heparin multilayer coatings for blood-contacting medical devices.
    Brynda E; Houska M; Jirousková M; Dyr JE
    J Biomed Mater Res; 2000 Aug; 51(2):249-57. PubMed ID: 10825225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulant activity of heparin octasaccharide.
    Ototani N; Yosizawa Z
    J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of high and low wall shear rates on the inhibition of factor Xa and thrombin at surfaces coated with immobilized heparin.
    Arnander C; Pasche B; Kodama K; Rasmuson A; Olsson P
    Artif Organs; 1989 Dec; 13(6):521-6. PubMed ID: 2604595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiochemical characterization of methotrexate-bovine serum albumin conjugates.
    Halbert GW; Florence AT
    J Pharm Pharmacol; 1989 Apr; 41(4):222-6. PubMed ID: 2568459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100.
    Cardin AD; Barnhart RL; Witt KR; Jackson RL
    Thromb Res; 1984 Jun; 34(6):541-50. PubMed ID: 6740570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic activity and platelet reactivity of heparin covalently bonded to surfaces.
    Lindon JN; Salzman EW; Merrill EW; Dincer AK; Labarre D; Bauer KA; Rosenberg RR
    J Lab Clin Med; 1985 Feb; 105(2):219-26. PubMed ID: 3973461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of thrombin inactivation by immobilized heparin.
    Byun Y; Jacobs HA; Kim SW
    J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.